CFMS News and Press, Conformis Inc. From 07/30/20

Background: I am an orthopedic surgeon in a busy practice. I have used Flexion's (FLXN) knee arthritis product Zilretta clinically, and I have met with the sales representative from Flexion on three occasions. I have performed approximately 20 Zilretta injections. I do not think the proponents...

BILLERICA, Mass., July 23, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that management will present at the Canaccord Genuity 40th Annual Growth Conference. The event is being held virtually and will take place between August 11 and 13, 2020.  For more informa...

Conformis (NASDAQ: CFMS ) sees Q2 total revenue of ~$19.5M (-1% Y/Y), Product revenue of ~$9.7M (-50% Y/Y). More news on: Conformis, Inc., Healthcare stocks news, , Stocks on the move Read more ...

Earnings Call to be Hosted on August 5, 2020 BILLERICA, Mass., July 06, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants de...

BILLERICA, Mass., June 22, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) today announced 510(k) clearance by the U.S. Food and Drug Administration of the Company’s next generation iTotal ® Identity PS Knee System. The iTotal ® Identity PS Knee System uses...

BILLERICA, Mass., May 28, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that it has entered into a settlement and license agreement with Zimmer Biomet Holdings, Inc., Zimmer, Inc., Zimmer US, Inc., and Biomet Manufacturing, LLC (together, “Zimmer Biometȁ...

BILLERICA, Mass., May 21, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) congratulates Dr. Malte Asseln for winning the prestigious Klee Prize 2020 for his dissertation and computer-and-image-based workflow on the optimization of knee implant design - “Morphological and Func...

Conformis, Inc. (CFMS) Q1 2020 Earnings Conference Call May 11, 2020 04:30 PM ET Company Participants Mark Augusti - President & CEO Bob Howe - CFO Conference Call Participants Joshua Jennings - Cowen Steven Lichtman - Oppenheimer Robert Marcus - JP Morgan Presenta...

ConforMIS (NASDAQ: CFMS ): Q1 GAAP EPS of -$0.14 misses by $0.05 . More news on: Conformis, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

BILLERICA, Mass., May 11, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture, and sell patient-specific joint replacement implants designed to fit each patient's uni...